News and Trends 17 Apr 2023
Aer Therapeutics raises $36M to tackle lung diseases
Aer Therapeutics, a joint University College Dublin (UCD) and University of California, San Francisco (UCSF) biopharmaceutical spin-out company developing novel inhaled treatments for muco-obstructive lung diseases, has announced the closing…